Skip to main content

Table 4 Adverse events

From: Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study

 

Level 1

Level 2

Level 3

 

All

G3

All

G3

All

G3

All (%)

G3 (%)

Hematologic toxicities

 Neutropenia

3

3

2

1

1

1

6 (66.7)

5 (55.6)

 Anemia

2

0

1

0

1

1

4(44.4)

1 (11.1)

 Thrombocytopenia

0

0

1

0

2

0

3 (33.3)

0 (0.0)

Non-hematologic toxicities

 Elevated AST

3

0

3

1

3

3

9 (100)

3(33.3)

 Elevated ALT

1

0

1

1

3

0

5(55.6)

1(11.1)

 Increased serum bilirubin

3

0

0

0

0

0

3 (33.3)

0 (0.0)

 Fever

0

0

2

0

0

0

2 (22.2)

0 (0.0)

 Abdominal Pain

2

0

2

0

3

0

7(77.8)

0 (0.0)

  1. G3 grade 3
  2. No grade 4 toxicities were found